Education
About Us
Working with TipRanks
Follow Us
Betterlife Pharma Inc. (TSE:BETR)
:BETR
BETR Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.20
Previous CloseN/A
Volume50.00
Average Volume (3M)38.68K
Market Cap
C$14.55M
Enterprise ValueC$14.16M
Total Cash (Recent Filing)C$126.31K
Total Debt (Recent Filing)C$1.94M
Price to Earnings (P/E)―
Beta0.12
Next Earnings
Jun 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding145,494,890
10 Day Avg. Volume29,752
30 Day Avg. Volume38,683
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)-1.21
Price to Sales (P/S)0.00
P/FCF Ratio-8.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BetterLife Pharma News
PremiumCompany Announcements
BetterLife Pharma Secures Patent for BETR-001, Strengthening Biotech Position
PremiumCompany Announcements
BetterLife Pharma Advances BETR-001 for Neuro-Psychiatric DisordersPremiumCompany Announcements
BetterLife Pharma Clarifies CEO’s Share Ownership Amid BCSC Announcement
PremiumCompany Announcements
BetterLife Pharma Advances BETR-001 for Psychiatric Treatment
Options Prices
Currently, No data available
---
Ownership Overview
36.58% Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
63.41% Public Companies and
Individual Investors
BETR FAQ
What was Betterlife Pharma Inc.’s price range in the past 12 months?
Betterlife Pharma Inc. lowest stock price was C$0.08 and its highest was C$0.20 in the past 12 months.
What is Betterlife Pharma Inc.’s market cap?
Betterlife Pharma Inc.’s market cap is C$14.55M.
When is Betterlife Pharma Inc.’s upcoming earnings report date?
Betterlife Pharma Inc.’s upcoming earnings report date is Jun 25, 2025 which is in 2 days.
How were Betterlife Pharma Inc.’s earnings last quarter?
Currently, no data Available
Is Betterlife Pharma Inc. overvalued?
According to Wall Street analysts Betterlife Pharma Inc.’s price is currently Overvalued.
Does Betterlife Pharma Inc. pay dividends?
Betterlife Pharma Inc. does not currently pay dividends.
What is Betterlife Pharma Inc.’s EPS estimate?
Betterlife Pharma Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Betterlife Pharma Inc. have?
Betterlife Pharma Inc. has 145,494,890 shares outstanding.
What happened to Betterlife Pharma Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Betterlife Pharma Inc.?
Currently, no hedge funds are holding shares in TSE:BETR
Company Description
Betterlife Pharma Inc.
BetterLife Pharma Inc. is a biotechnology company engaged in the development and commercialization of therapeutic products for mental health disorders. The company operates in the healthcare sector, focusing on the research and development of novel compounds for the treatment of depression, anxiety, and other neurological conditions. BetterLife Pharma's core products include psychedelic-based therapies and treatments designed to improve mental health outcomes.